Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes

Aims. Efficacy and safety of DPP-4 inhibitor, sitagliptin, add-on therapy to insulin were investigated in Japanese patients with type 2 diabetes. Subjects and Methods. Two hundred and sixteen patients (126 men, 65 ± 12 years old, BMI 24.9 ± 4.5, means ± S.D.) who had been treated by insulin alone or...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajiri, Yuji, Kawano, Seiko, Hirao, Saori, Oshige, Tamami, Iwata, Shinpei, Ono, Yasuhiro, Inada, Chizuko, Akashi, Tomoyuki, Hayashi, Hideki, Sato, Yuichi, Tojikubo, Masayuki, Yamada, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897314/
https://www.ncbi.nlm.nih.gov/pubmed/27419209
http://dx.doi.org/10.1155/2014/639489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897314/
https://www.ncbi.nlm.nih.gov/pubmed/27419209
http://dx.doi.org/10.1155/2014/639489

Ejemplares similares